Integrating Quality Control: Studies of UBQLN2 in Age-Related Neurodegeneration
整合质量控制:UBQLN2 在年龄相关神经退行性疾病中的研究
基本信息
- 批准号:10200456
- 负责人:
- 金额:$ 15.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinAddressAffectAnimal ModelAutomobile DrivingBehaviorBiochemicalBiochemistryBiophysicsBrainBrain DiseasesCellsCytoplasmic InclusionDepositionDiseaseGoalsHomeostasisImpairmentIn VitroKnowledgeLinkMediatingMicroscopyMolecularMusMutationNerve DegenerationNervous system structureNeurodegenerative DisordersNeuronsPathogenesisPathogenicityPathologicPathologyPathway interactionsPhysiologicalPlayProbabilityPropertyProteinsProteomicsQuality ControlRoleRouteSeedsSolubilityStructureSystemTechnical ExpertiseTechniquesToxic effectTransgenic MiceUBQLN1 geneUbiquitinUbiquitin familyage related neurodegenerationbasebrain healthdimerdisease-causing mutationfrontotemporal lobar dementia-amyotrophic lateral sclerosisinsightmouse modelmutantneurotoxicitynovelprotein TDP-43protein aggregationproteostasisreceptorubiquilin
项目摘要
Abstract
Mutations in Ubiquilin2 (UBQLN2) were recently identified as a cause of Frontotemporal Dementia and
Amyotrophic Lateral Sclerosis (FTD/ALS) associated with TDP43 deposition, and UBQLN2 itself has emerged
as a sensitive marker of pathology in a substantial portion of sporadic and familial FTD/ALS. UBQLN2 is also
one of four closely related ubiquilins, a family of ubiquitin adaptor proteins implicated in ubiquitin-dependent
protein quality control in the nervous system. Although mounting evidence implicates UBQLN2 and other
ubiquilins in numerous age-related neurodegenerative diseases defined by protein accumulation, their
functions in brain health and disease remain poorly understood. Moreover, the mechanisms by which
mutations in UBQLN2 cause FTD/ALS are unknown. The current proposal investigates these critical gaps in
knowledge. Our primary goals are to define pathogenic mechanisms in UBQLN2-mediated FTD/ALS and to
gain insight into the cellular pathways driving TDP43 deposition and neurodegeneration in FTD/ALS. In three
specific aims employing complementary approaches (biochemistry, animal models, and automated
microscopy), our investigative team will seek to 1) define the molecular properties driving aggregation of
mutant UBQLN2, 2) explore the functional consequences of UBQLN2 aggregation in mouse models, and 3)
investigate how mutant UBQLN2 alters TDP43 homeostasis in neurons. The proposed studies build on: novel
biochemical insights into the distinct properties of wild type and mutant UBQLN2; newly generated mouse
models expressing wild type or mutant UBQLN2 that show robust aggregate pathology selectively in mutant
UBQLN2 mice; a completed proteomics screen demonstrating that wild-type UBQLN2 interacts with the two
other brain-expressed ubiquilins, UBQLN1 and UBQLN4; and evidence that TDP43-positive cytoplasmic
puncta accumulate in neurons of mutant UBQLN2 mice, offering a pathway to explore functional links between
UBQLN2 and TDP43. The proposed multi-system approach greatly increases the probability of uncovering
disease mechanisms in FTD/ALS and achieving our long-term objective of finding routes to therapy for this
spectrum of fatal, age-related neurodegenerative diseases.
抽象的
最近发现泛素 2 (UBQLN2) 突变是导致额颞叶痴呆的原因之一
与 TDP43 沉积相关的肌萎缩侧索硬化症 (FTD/ALS) 以及 UBQLN2 本身已经出现
作为大部分散发性和家族性 FTD/ALS 病理学的敏感标志物。 UBQLN2 也是
四种密切相关的泛素之一,是涉及泛素依赖性的泛素接头蛋白家族
神经系统中的蛋白质质量控制。尽管越来越多的证据表明 UBQLN2 和其他
泛素在许多由蛋白质积累定义的与年龄相关的神经退行性疾病中,其
大脑健康和疾病中的功能仍然知之甚少。此外,其机制
UBQLN2 突变导致 FTD/ALS 的情况尚不清楚。当前的提案调查了这些关键差距
知识。我们的主要目标是定义 UBQLN2 介导的 FTD/ALS 的致病机制并
深入了解 FTD/ALS 中驱动 TDP43 沉积和神经变性的细胞途径。三分之内
采用互补方法(生物化学、动物模型和自动化)的具体目标
显微镜),我们的研究团队将寻求 1)定义驱动聚集的分子特性
突变体 UBQLN2,2) 探索小鼠模型中 UBQLN2 聚集的功能后果,以及 3)
研究突变体 UBQLN2 如何改变神经元中 TDP43 稳态。拟议的研究建立在:新颖
对野生型和突变型 UBQLN2 独特特性的生化见解;新生成的鼠标
表达野生型或突变型 UBQLN2 的模型,在突变型中选择性地显示出强大的聚合病理学
UBQLN2小鼠;完整的蛋白质组学筛选证明野生型 UBQLN2 与两者相互作用
其他脑表达的泛素、UBQLN1 和 UBQLN4;以及 TDP43 阳性细胞质的证据
puncta 在突变型 UBQLN2 小鼠的神经元中积累,为探索之间的功能联系提供了一条途径
UBQLN2 和 TDP43。所提出的多系统方法大大增加了发现的可能性
FTD/ALS 的疾病机制,并实现我们寻找治疗途径的长期目标
一系列致命的、与年龄相关的神经退行性疾病。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aggregation and the Intrinsic Structural Disorder of Dipeptide Repeat Peptides of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Characterized by NMR.
NMR 表征的 C9orf72 相关肌萎缩侧索硬化症和额颞叶痴呆的二肽重复肽的聚集和内在结构紊乱。
- DOI:10.1021/acs.jpcb.1c08149
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Krishnarjuna,Bankala;Ivanova,MagdalenaI;Ramamoorthy,Ayyalusamy
- 通讯作者:Ramamoorthy,Ayyalusamy
Conformational Tuning of Amylin by Charged Styrene-Maleic-Acid Copolymers.
- DOI:10.1016/j.jmb.2021.167385
- 发表时间:2022-01-30
- 期刊:
- 影响因子:5.6
- 作者:Sahoo BR;Souders CL 2nd;Watanabe-Nakayama T;Deng Z;Linton H;Suladze S;Ivanova MI;Reif B;Ando T;Martyniuk CJ;Ramamoorthy A
- 通讯作者:Ramamoorthy A
Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology.
- DOI:10.1016/j.bpc.2020.106507
- 发表时间:2021-02
- 期刊:
- 影响因子:3.8
- 作者:Ivanova MI;Lin Y;Lee YH;Zheng J;Ramamoorthy A
- 通讯作者:Ramamoorthy A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Magdalena I Ivanova其他文献
Ganglioside GM1 produces stable, short, and cytotoxic Aβsub40/sub protofibrils
神经节苷脂 GM1 产生稳定、短且具有细胞毒性的 Aβ40 原纤维
- DOI:
10.1039/d3cc02186f - 发表时间:
2023-01-01 - 期刊:
- 影响因子:4.200
- 作者:
Manjeet Kumar;Magdalena I Ivanova;Ayyalusamy Ramamoorthy - 通讯作者:
Ayyalusamy Ramamoorthy
Magdalena I Ivanova的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant